Tag: Q1FY25
Biocon reports 30% revenue increase and ₹660 crore net profit in...
Biocon's Q1FY25 performance sees 117% EBITDA growth and ₹660 crore net profit, powered by strategic partnerships and biosimilar success
Indegene Limited reports 11.4% revenue growth in Q1FY25
Indegene achieves robust growth, becoming a zero-debt entity and anticipating continued momentum with key clients